Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, November 08, 2016 ) DelveInsight's, "Factor IX-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Factor IX. The DelveInsight's Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight's Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Factor IX. DelveInsight's Report also assesses the Factor IX therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration. For more information about this report: http://www.reportsweb.com/factor-ix-pipeline-insights-2016
Table of Contents - Factor IX Overview - Factor IX Disease Associated - Factor IX Pipeline Therapeutics - Factor IX Therapeutics under Development by Companies - Factor IX Filed and Phase III Products - Comparative Analysis - Factor IX Phase II Products - Comparative Analysis - Factor IX Phase I and IND Filed Products - Comparative Analysis
Request Sample Copy at http://www.reportsweb.com/inquiry&RW000184325/sample
- Factor IX Discovery and Pre-Clinical Stage Products - Comparative Analysis - Drug Candidate Profiles - Factor IX - Therapeutics Assessment - Assessment by Monotherapy Products - Assessment by Combination Products - Assessment by Route of Administration - Assessment by Molecule Type - Factor IX - Discontinued Products - Factor IX - Dormant Products - Companies Involved in Therapeutics Development for Factor IX
Inquire before Buying at http://www.reportsweb.com/inquiry&RW000184325/buying
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
Source: EmailWire.com
|
|
|
|